- Home
- SNTI vs INTZ Comparison
SNTI vs INTZ Comparison
Compare SNTI & INTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- INTZ
- Stock Information
- Founded
- SNTI 2016
- INTZ 1983
- Country
- SNTI United States
- INTZ United States
- Employees
- SNTI N/A
- INTZ N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- INTZ Computer Communications Equipment
- Sector
- SNTI Health Care
- INTZ Telecommunications
- Exchange
- SNTI Nasdaq
- INTZ Nasdaq
- Market Cap
- SNTI 39.6M
- INTZ 33.2M
- IPO Year
- SNTI N/A
- INTZ 2020
- Fundamental
- Price
- SNTI $1.39
- INTZ $1.78
- Analyst Decision
- SNTI Strong Buy
- INTZ Buy
- Analyst Count
- SNTI 2
- INTZ 2
- Target Price
- SNTI $8.50
- INTZ $6.50
- AVG Volume (30 Days)
- SNTI 121.1K
- INTZ 143.9K
- Earning Date
- SNTI 11-13-2025
- INTZ 10-08-2025
- Dividend Yield
- SNTI N/A
- INTZ N/A
- EPS Growth
- SNTI N/A
- INTZ N/A
- EPS
- SNTI N/A
- INTZ N/A
- Revenue
- SNTI N/A
- INTZ $6,828,000.00
- Revenue This Year
- SNTI N/A
- INTZ $36.75
- Revenue Next Year
- SNTI $150.00
- INTZ $30.90
- P/E Ratio
- SNTI N/A
- INTZ N/A
- Revenue Growth
- SNTI N/A
- INTZ 25.86
- 52 Week Low
- SNTI $1.26
- INTZ $0.35
- 52 Week High
- SNTI $16.94
- INTZ $7.34
- Technical
- Relative Strength Index (RSI)
- SNTI 39.50
- INTZ 52.15
- Support Level
- SNTI $1.33
- INTZ $1.65
- Resistance Level
- SNTI $1.42
- INTZ $1.82
- Average True Range (ATR)
- SNTI 0.07
- INTZ 0.09
- MACD
- SNTI 0.02
- INTZ 0.01
- Stochastic Oscillator
- SNTI 44.83
- INTZ 80.95
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About INTZ Intrusion Inc.
Intrusion Inc is a cybersecurity company based in Plano, Texas. The group offers customers to access its threat intelligence database containing the historical data, known associations, and reputational behavior of Internet Protocol (IP) addresses. The company's product consists of On-Premise Network Protection, Cyber Threat Consulting, Cloud Network Security, and Endpoint Protection. Its solutions are INTRUSION Shield, INTRUSION TraceCop, and INTRUSION Savant. Its end-user customers include the U.S. federal government, state and local government entities, large and diversified conglomerates, and manufacturing entities.